SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 170 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $3,961,000 | +57.4% | 220,630 | +3.5% | 0.00% | +100.0% |
Q3 2017 | $2,517,000 | +81.9% | 213,246 | +61.8% | 0.00% | 0.0% |
Q2 2017 | $1,384,000 | -3.3% | 131,790 | +1.3% | 0.00% | 0.0% |
Q1 2017 | $1,431,000 | -74.1% | 130,100 | -74.3% | 0.00% | -66.7% |
Q1 2016 | $5,527,000 | -24.0% | 505,854 | +20.3% | 0.00% | -25.0% |
Q4 2015 | $7,273,000 | +389.1% | 420,655 | +462.1% | 0.00% | +300.0% |
Q3 2015 | $1,487,000 | +32.4% | 74,832 | +3.6% | 0.00% | 0.0% |
Q1 2015 | $1,123,000 | +10109.1% | 72,204 | +4073.6% | 0.00% | – |
Q3 2014 | $11,000 | -8.3% | 1,730 | 0.0% | 0.00% | – |
Q2 2014 | $12,000 | 0.0% | 1,730 | 0.0% | 0.00% | – |
Q1 2014 | $12,000 | -25.0% | 1,730 | 0.0% | 0.00% | – |
Q4 2013 | $16,000 | 0.0% | 1,730 | -33.0% | 0.00% | – |
Q3 2013 | $16,000 | -5.9% | 2,584 | -0.4% | 0.00% | – |
Q2 2013 | $17,000 | – | 2,594 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 1,304,376 | $23,414,000 | 7.30% |
Kassirer Asset Management Corp | 291,784 | $5,238,000 | 5.39% |
First Trust Capital Management L.P. | 637,578 | $11,445,000 | 2.19% |
NEXTHERA CAPITAL LP | 510,486 | $9,163,000 | 1.69% |
HAVENS ADVISORS LLC | 100,000 | $1,795,000 | 1.35% |
Piermont Capital Management Inc. | 172,980 | $3,105,000 | 1.02% |
PRELUDE CAPITAL MANAGEMENT, LLC | 674,446 | $12,106,000 | 0.97% |
ALPINE ASSOCIATES MANAGEMENT INC. | 1,495,600 | $26,845,000 | 0.96% |
LONGFELLOW INVESTMENT MANAGEMENT CO LLC | 200,000 | $3,590,000 | 0.87% |
BOOTHBAY FUND MANAGEMENT, LLC | 332,075 | $5,961,000 | 0.87% |